Chi-Fu Jeffrey Yang Selected Research

Chi-Fu Jeffrey Yang Research Topics

24	Neoplasms (Cancer) 12/2022 - 08/2012
23	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2022 - 01/2015
6	Lung Neoplasms (Lung Cancer) 10/2021 - 08/2012
3	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 12/2018 - 04/2016
2	Margins of Excision 02/2022 - 01/2018
2	Thymoma (Thymic Carcinoma) 01/2022 - 08/2020
2	Esophageal Neoplasms (Esophageal Cancer) 01/2022 - 01/2016
2	Liver Diseases (Liver Disease) 10/2010 - 06/2009
1	Esophageal Squamous Cell Carcinoma 02/2022
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2022
1	Adenocarcinoma of Lung 01/2022
1	Adenocarcinoma 01/2022
1	Sarcopenia 10/2021
1	Pneumonia (Pneumonitis) 08/2021
1	Pathologic Constriction (Stenosis) 08/2021
1	Deglutition Disorders (Dysphagia) 08/2021
1	Infections 08/2021
1	Fibrosis (Cirrhosis) 01/2021
1	Inflammation (Inflammations) 01/2021
1	Malignant Mesothelioma 11/2020
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 03/2018
1	Atrial Fibrillation 01/2018
1	Coronary Disease (Coronary Heart Disease) 06/2016
1	Hemorrhage 06/2016
1	Mediastinal Diseases 06/2016
1	Chronic Obstructive Pulmonary Disease (COPD) 06/2016
1	Stroke (Strokes) 01/2011
1	End Stage Liver Disease 10/2010
1	Intestinal Failure 10/2010
1	Short Bowel Syndrome 06/2009
1	Body Dysmorphic Disorders (Body Dysmorphic Disorder) 02/2005

1	Indicators and Reagents (Reagents)IBA 02/2022
1	Biomarkers (Surrogate Marker)IBA 03/2018
1	IpilimumabIBA 01/2018
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2016
1	Nitric Oxide Synthase (NO Synthase)IBA 01/2016
1	NG-Nitroarginine Methyl Ester (L-NAME)IBA 01/2016
1	Carbon MonoxideIBA 01/2015
1	Carbon DioxideIBA 10/2010
1	Methionine (L-Methionine)FDA Link 10/2010
1	Alanine Transaminase (SGPT)IBA 06/2009
1	Anabolic Androgenic SteroidsIBA 02/2005

15	Therapeutics 10/2021 - 01/2015
6	Radiotherapy 12/2022 - 06/2015
6	Segmental Mastectomy (Lumpectomy) 08/2021 - 08/2012
6	Thoracotomy 01/2021 - 08/2012
5	Drug Therapy (Chemotherapy) 11/2021 - 06/2015
5	Pneumonectomy (Lung Volume Reduction) 10/2021 - 12/2015
4	Esophagectomy 02/2022 - 01/2016
4	Induction Chemotherapy 01/2020 - 12/2015
4	Adjuvant Chemotherapy 07/2019 - 04/2016
2	Thymectomy 01/2022 - 08/2020
2	Treatment Delay 01/2022 - 01/2022
2	Immunotherapy 11/2021 - 01/2021
2	Neoadjuvant Therapy 11/2020 - 01/2018
1	Length of Stay 02/2022
1	Pyloromyotomy 08/2021
1	Patient Readmission 08/2021
1	Aftercare (After-Treatment) 01/2018
1	Cranial Irradiation 04/2016
1	Minimally Invasive Surgical Procedures 03/2016
1	Counterpulsation (External Counterpulsation) 01/2011
1	Parenteral Nutrition 06/2009